Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.

Krüger W, Stockschläder M, Sobottka I, Betker R, De Wit M, Kröger N, Grimm J, Arland M, Fiedler W, Erttmann R, Zander AR.

Leuk Lymphoma. 1997 Feb;24(5-6):491-9.

PMID:
9086439
2.

Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.

Krüger W, Stockschläder M, Rüssmann B, Berger C, Hoffknecht M, Sobottka I, Kohlschütter B, Kroschke G, Kröger N, Horstmann M, et al.

Br J Haematol. 1995 Nov;91(3):684-90.

PMID:
8555076
3.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
4.

Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B.

Krüger WH, Kröger N, Rüssmann B, Renges H, Kabisch H, Zander AR.

Bone Marrow Transplant. 1998 Dec;22 Suppl 4:S10-3.

PMID:
9916623
5.

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS.

N Engl J Med. 1999 Mar 11;340(10):764-71.

6.

Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B.

Krüger WH, Rüssmann B, de Wit M, Kröger N, Renges H, Sobottka I, Zander AR.

Acta Haematol. 2005;113(2):104-8.

PMID:
15802888
7.

Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.

Wolff SN, Fay J, Stevens D, Herzig RH, Pohlman B, Bolwell B, Lynch J, Ericson S, Freytes CO, LeMaistre F, Collins R, Pineiro L, Greer J, Stein R, Goodman SA, Dummer S.

Bone Marrow Transplant. 2000 Apr;25(8):853-9.

8.

Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients.

Chopra R, Blair S, Strang J, Cervi P, Patterson KG, Goldstone AH.

J Antimicrob Chemother. 1991 Oct;28 Suppl B:93-104.

PMID:
1778896
9.

Fatal outcome of disseminated candidosis after allogeneic bone marrow transplantation under treatment with liposomal and conventional amphotericin-B. A report of 4 cases with determination of the Mic values.

Krüger W, Sobottka I, Stockschläder M, Mross K, Hoffknecht M, Rüssmann B, Horstmann M, Betker R, Zander A.

Scand J Infect Dis. 1996;28(3):313-6.

PMID:
8863370
10.

[Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial].

Rieger CT, Dittmer M, Ostermann H.

Dtsch Med Wochenschr. 2007 Oct;132(40):2062-6. German.

PMID:
17899499
11.

Triple antifungal therapy for severe systemic candidiasis allowed performance of allogeneic stem cell transplantation.

Gahn B, Schub N, Repp R, Gramatzki M.

Eur J Med Res. 2007 Aug 16;12(8):337-40.

PMID:
17933709
13.
14.

Treatment of deep mycoses with liposomal amphotericin B.

Berenguer J, Muñoz P, Parras F, Fernández-Baca V, Hernández-Sampelayo T, Bouza E.

Eur J Clin Microbiol Infect Dis. 1994 Jun;13(6):504-7.

PMID:
7957273
16.

Treatment of systemic fungal infections with liposomal amphotericin B.

Lopez-Berestein G, Bodey GP, Fainstein V, Keating M, Frankel LS, Zeluff B, Gentry L, Mehta K.

Arch Intern Med. 1989 Nov;149(11):2533-6.

PMID:
2818111
17.

Use of amphotericin B colloidal dispersion in children.

Sandler ES, Mustafa MM, Tkaczewski I, Graham ML, Morrison VA, Green M, Trigg M, Abboud M, Aquino VM, Gurwith M, Pietrelli L.

J Pediatr Hematol Oncol. 2000 May-Jun;22(3):242-6.

PMID:
10864055
18.

Use of liposomal amphotericin B in bone marrow transplant.

Sastry PS, Parikh PM, Kulkarni PS, Bhagwat R, Gadade H.

J Postgrad Med. 2005;51 Suppl 1:S49-52. Review.

19.

Assessment of nephrotoxicity of high-cumulative dose of liposomal amphotericin B in a pediatric patient who underwent allogeneic bone marrow transplantation.

Cesaro S, Zignol M, Burlina AB, Tridello G, Visintin G, Messina C.

Pediatr Transplant. 2006 Mar;10(2):255-8.

PMID:
16573618
20.

Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.

Andström EE, Ringdén O, Remberger M, Svahn BM, Tollemar J.

Mycoses. 1996 May-Jun;39(5-6):185-93.

PMID:
8909028
Items per page

Supplemental Content

Write to the Help Desk